Tissue Management

Latest Issue of OR Manager
December 2017

Study: Restrictive vs liberal blood transfusion outcomes in cardiac surgery patients

Editor's Note A restrictive blood transfusion strategy (HGB <7.5 g/dL) was equivalent to a liberal strategy (HGB <9.5 g/dL in the OR or ICU and HGB<8.5 g/dL in the non-ICU ward) with regard to mortality and major disability in cardiac surgery patients who had a moderate-to-high risk of death, this…

Read More

By: Judy Mathias
November 16, 2017
Share

Joint Commission updates Patient Blood Management standards

Editor's Note The Joint Commission on November 8 announced the update of its Patient Blood Management standards to align with AABB standards. Among the changes: educational requirements for those who order and/or transfuse blood defined guidelines on transfusion orders procedures for emergent/urgent patients, including massive blood loss intraoperative methods for…

Read More

By: Judy Mathias
November 10, 2017
Share

Effect of organ donor hospital volume on transplantable organs

Editor's Note Hospitals managing the highest volume of deceased organ donors were 52% more likely to recover an above-average number of transplantable organs per donor than low-volume hospitals in this study. The study included data from 4,427 donors across 384 hospitals. High-volume hospitals had an organ yield (ie, rate of…

Read More

By: Judy Mathias
January 19, 2017
Share

FDA issues tissue, cell donation recommendations to reduce Zika virus risk

Editor's Note The Food and Drug Administration (FDA) on March 1 released new guidelines to prevent the transmission of the Zika virus from human cells, tissues, and cellular and tissue-based products. The guidance addresses both living and deceased donations of corneas, bone, skin, heart valves, hematopoietic stem/progenitor cells, gestational tissues…

Read More

By: Judy Mathias
March 3, 2016
Share

Safety, cost savings, simplicity back broader use of bloodless surgery

More than 120 centers throughout the US have bloodless surgery programs to serve patients who refuse blood transfusions for religious and other reasons. The practice, which began more than 50 years ago, has evolved through research on blood conservation and new techniques to minimize the need for transfusions. The Joint…

Read More

By: OR Manager
May 1, 2013
Share

Reaching New Heights with Advanced Business Management Concepts for the Veteran Manager

After this session you’ll be able to: 1. Discuss the benefits of strategic planning and how it differs by environment. 2. List 3 enhancements that take traditional value analysis further in impact on surgical margin. 3. Develop a business plan for a new program. Why this is important: The perioperative…

Read More

Event Session
Share

A sound process for acquiring tissue

A surgeon has requested a new tissue graft not in the current inventory. From the company's literature, it's not easy to tell whether the tissue is similar to others already in stock. Decisions like these are challenging because tissue grafts come with a host of safety, clinical, and cost issues.…

Read More

By: Pat Patterson
March 1, 2011
Share

Bone allografts: Options for healing

These are examples of types of bone allograft products and purposes they serve. With the chart on page 12, this information can help OR teams determine where a new allograft product would fit into current inventory. Allograft cancellous chips Cancellous chips, a common nonstructural human allograft bone material, serve as…

Read More

By: OR Manager
March 1, 2011
Share

Donor screening: First step in safety

Screening of tissue donors is a critical step in ensuring tissue safety. Screening is a complex, multidisciplinary process that begins every time a family says "yes" to the option of donation and ends when tissue is released for transplant. Tissue banks vary in what is considered a suitable donor. Regulating…

Read More

By: OR Manager
March 1, 2011
Share

Regulating allograft tissue

When your OR is selecting allograft tissue, how do you know which federal regulations govern their safety? The US Food and Drug Administration (FDA) uses a tiered approach to regulating these materials, explains Scott Brubaker, CTBS, chief policy officer for the American Association of Tissue Banks (AATB). Minimally processed tissue…

Read More

By: OR Manager
March 1, 2011
Share

Welcome

To our readers, Chips, pastes, putties, gels, powders, wedges, DBM, BMP, and assorted kits—the list of bone allografts and substitutes is long and confusing. These biologic materials have a big impact on the OR budget, but they are more than just another line of surgical supplies. Biologics originate with a…

Read More

By: OR Manager
March 1, 2011
Share

New Manager Bootcamp: Making the Transition into Management by Mastering Human Resources

The first step into management is a doozy…not only do you have increased responsibility reporting to a committee, but you are also now responsible for the group and individual successes of a team, many of whom were your peers not too long ago. You must first learn to distinguish yourself…

Read More

Event Session
Share
Hot Products
Product Spotlight: Sunrise Surgical Care

Sunrise™ Surgical Care provides health systems with the preoperative and perioperative care needed to continue driving patient safety, managing costs and optimizing hospital revenue

Live chat by BoldChat